Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Insight68 is a specialized software company providing digital orchestration solutions for the cell and gene therapy (CGT) industry. The company's platform is designed to manage the complex supply chain and manufacturing workflows inherent in personalized medicine, ensuring rigorous Chain of Identity (COI) and Chain of Custody (COC) tracking. By integrating disparate data sources and automating compliance-heavy processes, Insight68 helps biotech firms accelerate the delivery of advanced therapies to patients. Their technology focuses on scalability, transparency, and reducing the risk of manual errors in the vein-to-vein journey. The platform serves as a centralized hub for stakeholders including clinical sites, manufacturers, and logistics providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Insight68.